Annual Interest Expense
$1.63 B
+$296.00 M+22.26%
31 December 2023
Summary:
AstraZeneca annual interest expense is currently $1.63 billion, with the most recent change of +$296.00 million (+22.26%) on 31 December 2023. During the last 3 years, it has risen by +$354.00 million (+27.83%). AZN annual interest expense is now at all-time high.AZN Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Interest Expense
$457.00 M
+$14.00 M+3.16%
30 September 2024
Summary:
AstraZeneca quarterly interest expense is currently $457.00 million, with the most recent change of +$14.00 million (+3.16%) on 30 September 2024. Over the past year, it has increased by +$65.00 million (+16.58%). AZN quarterly interest expense is now at all-time high.AZN Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Interest Expense
$1.72 B
+$65.00 M+3.93%
30 September 2024
Summary:
AstraZeneca TTM interest expense is currently $1.72 billion, with the most recent change of +$65.00 million (+3.93%) on 30 September 2024. Over the past year, it has increased by +$189.00 million (+12.34%). AZN TTM interest expense is now at all-time high.AZN TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AZN Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +22.3% | +16.6% | +12.3% |
| 3 y3 years | +27.8% | +36.4% | +37.6% |
| 5 y5 years | +19.0% | +29.5% | +26.1% |
AZN Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +27.8% | at high | +47.0% | at high | +37.6% |
| 5 y | 5 years | at high | +27.8% | at high | +59.2% | at high | +38.8% |
| alltime | all time | at high | +1597.2% | at high | +347.0% | at high |
AstraZeneca Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $457.00 M(+3.2%) | $1.72 B(+3.9%) |
| June 2024 | - | $443.00 M(+7.3%) | $1.66 B(+0.7%) |
| Mar 2024 | - | $413.00 M(+1.2%) | $1.64 B(+3.0%) |
| Dec 2023 | $1.63 B(+22.3%) | $408.00 M(+4.1%) | $1.60 B(+4.2%) |
| Sept 2023 | - | $392.00 M(-9.0%) | $1.53 B(+3.6%) |
| June 2023 | - | $431.00 M(+18.1%) | $1.48 B(+8.8%) |
| Mar 2023 | - | $365.00 M(+6.1%) | $1.36 B(+2.2%) |
| Dec 2022 | $1.33 B(+4.2%) | $344.00 M(+1.5%) | $1.33 B(+2.5%) |
| Sept 2022 | - | $339.00 M(+9.0%) | $1.30 B(+0.3%) |
| June 2022 | - | $311.00 M(-7.4%) | $1.29 B(-1.1%) |
| Mar 2022 | - | $336.00 M(+7.7%) | $1.31 B(+2.6%) |
| Dec 2021 | $1.28 B(+0.3%) | $312.00 M(-6.9%) | $1.28 B(+2.0%) |
| Sept 2021 | - | $335.00 M(+2.8%) | $1.25 B(+0.9%) |
| June 2021 | - | $326.00 M(+7.6%) | $1.24 B(-0.2%) |
| Mar 2021 | - | $303.00 M(+5.6%) | $1.24 B(-2.3%) |
| Dec 2020 | $1.27 B(-9.3%) | $287.00 M(-11.4%) | $1.27 B(-2.6%) |
| Sept 2020 | - | $324.00 M(-1.5%) | $1.31 B(-2.2%) |
| June 2020 | - | $329.00 M(-0.9%) | $1.33 B(-2.3%) |
| Mar 2020 | - | $332.00 M(+3.4%) | $1.37 B(-2.5%) |
| Dec 2019 | $1.40 B(+2.6%) | $321.00 M(-9.1%) | $1.40 B(+2.7%) |
| Sept 2019 | - | $353.00 M(-2.2%) | $1.36 B(-0.8%) |
| June 2019 | - | $361.00 M(-1.6%) | $1.38 B(-1.0%) |
| Mar 2019 | - | $367.00 M(+29.2%) | $1.39 B(+1.8%) |
| Dec 2018 | $1.37 B(+0.4%) | $284.00 M(-22.0%) | $1.37 B(+9.9%) |
| Sept 2018 | - | $364.00 M(-2.9%) | $1.24 B(-4.2%) |
| June 2018 | - | $375.00 M(+9.3%) | $1.30 B(-5.3%) |
| Mar 2018 | - | $343.00 M(+113.0%) | $1.37 B(+0.2%) |
| Dec 2017 | $1.36 B(-0.5%) | $161.00 M(-61.5%) | $1.37 B(-11.9%) |
| Sept 2017 | - | $418.00 M(-6.7%) | $1.55 B(+4.2%) |
| June 2017 | - | $448.00 M(+31.8%) | $1.49 B(+7.7%) |
| Mar 2017 | - | $340.00 M(-1.4%) | $1.38 B(+1.1%) |
| Dec 2016 | $1.37 B(+31.6%) | $345.00 M(-2.8%) | $1.37 B(+7.0%) |
| Sept 2016 | - | $355.00 M(+3.8%) | $1.28 B(+9.3%) |
| June 2016 | - | $342.00 M(+5.2%) | $1.17 B(+6.0%) |
| Mar 2016 | - | $325.00 M(+27.0%) | $1.10 B(+6.2%) |
| Dec 2015 | $1.04 B(+7.9%) | $256.00 M(+4.1%) | $1.04 B(-0.4%) |
| Sept 2015 | - | $246.00 M(-10.9%) | $1.04 B(+1.0%) |
| June 2015 | - | $276.00 M(+5.7%) | $1.03 B(+2.3%) |
| Mar 2015 | - | $261.00 M(+0.4%) | $1.01 B(+5.0%) |
| Dec 2014 | $963.00 M(+95.7%) | $260.00 M(+10.2%) | $962.00 M(+15.1%) |
| Sept 2014 | - | $236.00 M(-6.7%) | $836.00 M(+14.8%) |
| June 2014 | - | $253.00 M(+18.8%) | $728.00 M(+22.1%) |
| Mar 2014 | - | $213.00 M(+59.0%) | $596.00 M(+19.7%) |
| Dec 2013 | $492.00 M | $134.00 M(+4.7%) | $498.00 M(+3.3%) |
| Sept 2013 | - | $128.00 M(+5.8%) | $482.00 M(-1.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2013 | - | $121.00 M(+5.2%) | $489.00 M(-2.6%) |
| Mar 2013 | - | $115.00 M(-2.5%) | $502.00 M(-3.3%) |
| Dec 2012 | $519.00 M(-6.3%) | $118.00 M(-12.6%) | $519.00 M(+140.3%) |
| Sept 2012 | - | $135.00 M(+0.7%) | $216.00 M(-33.9%) |
| June 2012 | - | $134.00 M(+1.5%) | $327.00 M(-25.0%) |
| Mar 2012 | - | $132.00 M(-171.4%) | $436.00 M(-21.3%) |
| Dec 2011 | $554.00 M(-45.8%) | -$185.00 M(-175.2%) | $554.00 M(-44.4%) |
| Sept 2011 | - | $246.00 M(+1.2%) | $996.00 M(-2.4%) |
| June 2011 | - | $243.00 M(-2.8%) | $1.02 B(0.0%) |
| Mar 2011 | - | $250.00 M(-2.7%) | $1.02 B(-0.7%) |
| Dec 2010 | $1.02 B(-2.9%) | $257.00 M(-5.2%) | $1.03 B(+12.1%) |
| Sept 2010 | - | $271.00 M(+11.5%) | $917.00 M(-2.8%) |
| June 2010 | - | $243.00 M(-5.4%) | $943.00 M(-9.1%) |
| Mar 2010 | - | $257.00 M(+76.0%) | $1.04 B(-1.5%) |
| Dec 2009 | $1.05 B(-20.0%) | $146.00 M(-50.8%) | $1.05 B(-12.3%) |
| Sept 2009 | - | $297.00 M(-11.9%) | $1.20 B(-1.4%) |
| June 2009 | - | $337.00 M(+23.4%) | $1.22 B(-0.1%) |
| Mar 2009 | - | $273.00 M(-6.8%) | $1.22 B(-7.5%) |
| Dec 2008 | $1.32 B(+902.0%) | $293.00 M(-6.7%) | $1.32 B(+28.6%) |
| Sept 2008 | - | $314.00 M(-7.1%) | $1.02 B(-3.5%) |
| June 2008 | - | $338.00 M(-9.1%) | $1.06 B(+12.4%) |
| Mar 2008 | - | $372.00 M(+6.0%) | $944.00 M(+30.7%) |
| Sept 2007 | - | $351.00 M(+58.8%) | $722.00 M(+41.3%) |
| June 2007 | - | $221.00 M(+47.3%) | $511.00 M(+76.2%) |
| Mar 2007 | - | $150.00 M(+7.1%) | $290.00 M(+107.1%) |
| Sept 2006 | - | $140.00 M(-62.4%) | $140.00 M(-62.4%) |
| Sept 2005 | - | $372.00 M(-532.6%) | $372.00 M(>+9900.0%) |
| June 2005 | - | -$86.00 M(-200.0%) | $0.00(-100.0%) |
| Mar 2005 | - | $86.00 M(>+9900.0%) | $86.00 M(>+9900.0%) |
| Mar 2004 | - | $0.00(0.0%) | $0.00(0.0%) |
| Sept 2003 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2003 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2003 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2001 | - | $0.00(-100.0%) | $131.44 M(0.0%) |
| Dec 2000 | $131.44 M(+30.3%) | $131.44 M(>+9900.0%) | $131.44 M(>+9900.0%) |
| Sept 2000 | - | $0.00(0.0%) | $0.00(0.0%) |
| June 2000 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2000 | - | $0.00 | $0.00 |
| Dec 1997 | $100.84 M(-8.0%) | - | - |
| Dec 1996 | $109.60 M(+14.4%) | - | - |
| Dec 1995 | $95.80 M(-18.3%) | - | - |
| Dec 1994 | $117.26 M(-42.1%) | - | - |
| Dec 1993 | $202.65 M(-28.5%) | - | - |
| Dec 1992 | $283.62 M(-27.8%) | - | - |
| Dec 1991 | $392.95 M(+0.8%) | - | - |
| Dec 1990 | $389.65 M | - | - |
FAQ
- What is AstraZeneca annual interest expense?
- What is the all time high annual interest expense for AstraZeneca?
- What is AstraZeneca annual interest expense year-on-year change?
- What is AstraZeneca quarterly interest expense?
- What is the all time high quarterly interest expense for AstraZeneca?
- What is AstraZeneca quarterly interest expense year-on-year change?
- What is AstraZeneca TTM interest expense?
- What is the all time high TTM interest expense for AstraZeneca?
- What is AstraZeneca TTM interest expense year-on-year change?
What is AstraZeneca annual interest expense?
The current annual interest expense of AZN is $1.63 B
What is the all time high annual interest expense for AstraZeneca?
AstraZeneca all-time high annual interest expense is $1.63 B
What is AstraZeneca annual interest expense year-on-year change?
Over the past year, AZN annual interest expense has changed by +$296.00 M (+22.26%)
What is AstraZeneca quarterly interest expense?
The current quarterly interest expense of AZN is $457.00 M
What is the all time high quarterly interest expense for AstraZeneca?
AstraZeneca all-time high quarterly interest expense is $457.00 M
What is AstraZeneca quarterly interest expense year-on-year change?
Over the past year, AZN quarterly interest expense has changed by +$65.00 M (+16.58%)
What is AstraZeneca TTM interest expense?
The current TTM interest expense of AZN is $1.72 B
What is the all time high TTM interest expense for AstraZeneca?
AstraZeneca all-time high TTM interest expense is $1.72 B
What is AstraZeneca TTM interest expense year-on-year change?
Over the past year, AZN TTM interest expense has changed by +$189.00 M (+12.34%)